On July 31, 2026, the Board of Directors of NewGenIvf Group Limited (the "Company") approved a reverse stock split of all of the Company’s issued and unissued shares, including the Class A ordinary shares with no par value (the "Class A Ordinary Shares"), Class B ordinary shares with no par value, and preferred shares with no par value, at an exchange ratio of one (1) share for three (3) shares (the "Reverse Stock Split"). Pursuant to the BVI Business Companies Act (as amended) and the Company’s M&A, the Company’s Board of Directors is authorized to effect the Reverse Share Split without the approval of the Company’s shareholders. Accordingly, no shareholder vote, consent or approval is required or will be sought in respect of the Reverse Share Split.

 

The Reverse Stock Split will be effective at 12:01 a.m. (ET) on September 1, 2026 (the "Record Date") and the Company’s Class A Ordinary Shares will begin trading on the Nasdaq Capital Market ("Nasdaq") on a split-adjusted basis at the opening of market on September 1, 2026.